Physician profile
Mark B Monahan
NPI 1679537021
$18,247.41
in general payments reported to CMS, 2019-2025
56 companies · $2,289 in 2025
The $2,289 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,208 · 2020: $1,185 · 2021: $1,758 · 2022: $2,332 · 2023: $2,208 · 2024: $3,268 · 2025: $2,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,049 · Travel and Lodging: $631 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,048.95 |
| Travel and Lodging | $630.82 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,739.24 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $1,864.88 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $1,247.32 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $1,051.76 | 2019-2025 | Xtandi |
| Abbvie INC. | $871.62 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $807.78 | 2019-2025 | |
| Histosonics, INC. | $753.58 | 2024-2025 | |
| Blue Earth Diagnostics | $732.19 | 2019-2023 | |
| Pfizer INC. | $720.92 | 2019-2025 | |
| Antares Pharma, INC. | $562.19 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $530.00 | 2019-2024 | Xiaflex, Aveed, Edex |
| Sumitomo Pharma America, INC. | $452.67 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $446.00 | 2020-2025 | Jelmyto |
| Teleflex LLC | $410.99 | 2021-2025 | Urolift, Barrigel |
| Progenics Pharmaceuticals, INC. | $370.23 | 2021-2025 | Pylarify |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $308.87 | 2019-2023 | Rezum Generator |
| Accord Healthcare, INC. | $257.39 | 2022-2024 | |
| Ferring Pharmaceuticals INC. | $225.18 | 2019-2025 | Adstiladrin |
| Endo USA, INC. | $204.85 | 2024-2025 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $203.30 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $202.46 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Procept Biorobotics Corporation | $199.42 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Neotract INC. | $188.52 | 2020 | |
| Amgen INC. | $177.67 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $175.12 | 2019-2025 | Yonsa |
| Ambu INC. | $150.85 | 2022-2024 | |
| Rochester Medical Corporation | $138.20 | 2019-2021 | |
| Myovant Sciences INC. | $131.41 | 2021-2022 | |
| Ethicon US, LLC | $106.52 | 2020-2023 | Stratafix, Echelon Flex |
| Laborie Medical Technologies Corp. | $105.47 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Travere Therapeutics, INC. | $88.77 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $75.91 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $61.37 | 2020-2021 | |
| Bard Access Systems, INC. | $56.83 | 2019 | |
| Urovant Sciences INC | $54.07 | 2021-2022 | |
| Profound Medical Corp. | $53.91 | 2025 | Tulsa-Pro |
| Photocure INC | $48.27 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $47.67 | 2023 | Surestep Foley Tray System Bardex I.C. Complete Care Foley Catheter |
| Davol INC. | $47.38 | 2023 | Arista Ah Flexitip |
| Halozyme INC | $41.85 | 2023 | |
| Olympus America INC. | $41.74 | 2025 | Itind System |
| Foundation Medicine, INC. | $34.27 | 2021-2022 | |
| Mission Pharmacal Company | $33.70 | 2019-2020 | |
| Tempus Ai, INC | $26.21 | 2024 | Xt Cdx |
| Calyxo, INC. | $22.95 | 2024 | Cvac Aspiration System |
| Azurity Pharmaceuticals, INC. | $22.04 | 2025 | Azmiro |
| Genzyme Corporation | $21.83 | 2023 | |
| Allergan, INC. | $19.57 | 2019 | |
| Cardinal Health 414 LLC | $18.89 | 2022 | |
| Innovation Technologies INC | $15.40 | 2020 | |
| Myriad Genetic Laboratories, INC. | $14.44 | 2021 | |
| Metuchen Pharmaceuticals | $13.31 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2023 | Seglentis |
| Verity Pharmaceuticals INC. | $13.02 | 2023 | Trelstar |
| Axonics, INC. | $12.51 | 2022 | |
| Clarus Therapeutics INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Monahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.